Evaluation of the Impact of a Regional Educational Advertising Campaign on Harm Perceptions of E-Cigarettes, Prevalence of E-Cigarette Use, and Quit Attempts Among Smokers.


Journal

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
ISSN: 1469-994X
Titre abrégé: Nicotine Tob Res
Pays: England
ID NLM: 9815751

Informations de publication

Date de publication:
12 06 2020
Historique:
received: 23 07 2019
accepted: 11 12 2019
pubmed: 15 12 2019
medline: 11 11 2020
entrez: 15 12 2019
Statut: ppublish

Résumé

We evaluated how effective an advertising campaign that was piloted by Cancer Research UK in January/February 2018 was at promoting quit attempts by increasing awareness of the relative harms of e-cigarettes compared with smoking. Adults (≥16 years, n = 2217) living in Greater Manchester (campaign region), Yorkshire & Humber and the North East of England (control regions) completed cross-sectional surveys immediately before and after the campaign period. Surveys measured socio-demographics, perceptions and use of e-cigarettes, and motivation and attempts to quit smoking. We tested interactions between time (pre, post) and region (campaign, control). 36.7% (95% CI 33.0%-40.6%) of those in the intervention region recognized the campaign. In the general population, interactions were nonsignificant for all outcomes except for perception of e-cigarettes as effective cessation aids, with smaller increases from pre- to post-campaign in the campaign (49.9% to 54.0%) compared with the control region (40.5% to 55.0%; odds ratio [OR] = 0.66, 95% CI .45-0.98). Among smokers, motivation to quit increased in the intervention region (44.0% to 48.0%) but decreased in the control region (40.5% to 21.5%; OR = 2.97, 95% confidence interval [CI] 1.25-7.16), with no other significant differences between regions over time. Bayes factors confirmed that nonsignificant results were inconclusive. Compared with the control region, the campaign was associated with an increase in smokers' motivation to quit but a smaller increase in adults' perception of e-cigarettes as an effective cessation aid. There was insufficient evidence to determine whether the campaign affected other outcomes. Past extended mass media tobacco control campaigns have been shown to change public attitudes towards smoking, improve motivation to quit smoking, and reduce smoking prevalence. Much less is known about shorter, targeted campaigns. Here we show that using mass media to communicate accurate information about the relative harms of e-cigarettes compared with smoking may be an effective strategy in increasing smokers' motivation to quit. Moreover, even when only run for a month, such campaigns can reach a large proportion of the targeted population. Further research is needed to evaluate effects on quit attempts and success.

Identifiants

pubmed: 31837223
pii: 5677516
doi: 10.1093/ntr/ntz236
pmc: PMC7291809
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1148-1154

Subventions

Organisme : Cancer Research UK
ID : C1417/A22962
Pays : United Kingdom

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco.

Références

BMJ. 2017 Jul 26;358:j3262
pubmed: 28747333
Nicotine Tob Res. 2015 Jun;17(6):704-9
pubmed: 25335945
Nicotine Tob Res. 2019 Feb 18;21(3):267
pubmed: 29931122
Ann Intern Med. 2017 Mar 21;166(6):390-400
pubmed: 28166548
Cochrane Database Syst Rev. 2014;(12):CD010216
pubmed: 25515689
Am J Public Health. 2001 Feb;91(2):233-8
pubmed: 11211631
Nicotine Tob Res. 2017 Feb;19(2):160-167
pubmed: 27613896
Addiction. 2019 Feb;114(2):294-303
pubmed: 30306714
N Engl J Med. 2019 Feb 14;380(7):629-637
pubmed: 30699054
Drug Alcohol Depend. 2013 Feb 1;128(1-2):15-9
pubmed: 22943961
Addiction. 2017 Oct;112(10):1832-1841
pubmed: 28556467
Tob Control. 2012 Mar;21(2):127-38
pubmed: 22345235
Am J Prev Med. 2009 May;36(5):379-84
pubmed: 19211213
Eur J Public Health. 2017 Feb 1;27(1):129-134
pubmed: 28177479
Cancer Prev Res (Phila). 2015 Sep;8(9):873-8
pubmed: 26333731
Am J Prev Med. 2015 Jan;48(1 Suppl 1):S78-85
pubmed: 25528713
BMJ. 2016 Sep 13;354:i4645
pubmed: 27624188
BMJ Open. 2018 Dec 4;8(12):e025370
pubmed: 30514823
BMC Med. 2018 Nov 14;16(1):206
pubmed: 30424771
Am J Prev Med. 2010 Jul;39(1):53-62
pubmed: 20537841

Auteurs

Harry Tattan-Birch (H)

Department of Behavioural Science and Health, University College London, London, UK.

Sarah E Jackson (SE)

Department of Behavioural Science and Health, University College London, London, UK.

Charlotte Ide (C)

Cancer Research UK, London, UK.

Linda Bauld (L)

Cancer Research UK, London, UK.
Usher Institute, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, UK.

Lion Shahab (L)

Department of Behavioural Science and Health, University College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH